Biomarker Found to Predict AKI in Emergency Patients

Share this article:

A prospective cohort study has shown plasma neutrophil gelatinase-associated lipocalin (NGAL) to be an accurate biomarker for predicting acute kidney injury (AKI) in patients admitted from the emergency department (ED).

As Prasad Devarajan, MD, and colleagues described in the Clinical Journal of the American Society of Nephrology, 21% of 616 persons admitted to a hospital from the ED were classified as AKI.

Compared with other patients, this group had the highest median levels of plasma NGAL (146 to 174 ng/mL at various time points), which increased with AKI severity (207 to 244 ng/mL).

The discriminative ability of plasma NGAL improved with higher grades of severity. The test distinguished AKI from normal function and transient azotemia, and could classify patients into low-, moderate-, and high-risk AKI. Use of plasma NGAL resulted in a net reclassification improvement of 94.3%.

Share this article:
You must be a registered member of RUN to post a comment.
close

Next Article in News in Brief

More in News in Brief

Reasons for Alpha Blocker Switch ID'd

Reasons for Alpha Blocker Switch ID'd

Lack of efficacy is the main reason for the switch.

Urodynamic Studies On the Upswing

Urodynamic Studies On the Upswing

Urodynamic studies for female Medicare patients increased by 29% from 2000 to 2010.

FDA Okays Rapid-Acting Inhaled Insulin

FDA Okays Rapid-Acting Inhaled Insulin

Afrezza is administered at the start of each meal or within 20 minutes after starting a meal.